Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000522614 | SCV000226888 | uncertain significance | not provided | 2018-06-12 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000522614 | SCV000618356 | likely pathogenic | not provided | 2024-05-30 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Identified in the heterozygous state in an individual with autism, epilepsy, and developmental delay, although the inheritance is unknown (PMID: 29056246); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 29056246) |
Genetics and Molecular Pathology, |
RCV002466460 | SCV002761514 | pathogenic | Pitt-Hopkins-like syndrome 2 | 2021-01-25 | criteria provided, single submitter | clinical testing | |
Juno Genomics, |
RCV004796068 | SCV005417161 | pathogenic | Pitt-Hopkins-like syndrome 2; Chromosome 2p16.3 deletion syndrome | criteria provided, single submitter | clinical testing | PM2_Supporting+PVS1+PS4_Supporting | |
Dash Lab, |
RCV000787967 | SCV000914238 | likely pathogenic | Obesity | 2018-07-01 | no assertion criteria provided | research |